1 – 5 of 10
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- Parents' and Adolescents' Preferences for Intensified or Reduced Treatment in Randomized Lymphoblastic Leukemia Trials.
- 2015
- Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid
- 2014
- Prognostic Implications of Mutations in NOTCH1 and FBXW7 in Childhood T-ALL Treated According to the NOPHO ALL-1992 and ALL-2000 Protocols
- 2013
-
Requirement of Apoptotic Protease-Activating Factor-1 for Bortezomib-Induced Apoptosis but Not for Fas-Mediated Apoptosis in Human Leukemic Cells
Ottosson-Wadlund, Astrid ; Ceder, Rebecca ; Preta, Giulio ; Pokrovskaja, Katja ; Grafstrom, Roland C. ; Heyman, Mats ; Soderhall, Stefan ; Grander, Dan ; Hedenfalk, Ingrid LU
and Robertson, John D.
, et al.
(2013)
In Molecular Pharmacology
83(1).
p.245-255
Mark
- 2011
- Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.